These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33122994)

  • 1. Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson's Disease.
    Gilmozzi V; Gentile G; Castelo Rueda MP; Hicks AA; Pramstaller PP; Zanon A; Lévesque M; Pichler I
    Front Neurosci; 2020; 14():578993. PubMed ID: 33122994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols.
    Camilleri A; Zarb C; Caruana M; Ostermeier U; Ghio S; Högen T; Schmidt F; Giese A; Vassallo N
    Biochim Biophys Acta; 2013 Nov; 1828(11):2532-43. PubMed ID: 23817009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
    Mori A; Imai Y; Hattori N
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein amino terminus regulates mitochondrial membrane permeability.
    Shen J; Du T; Wang X; Duan C; Gao G; Zhang J; Lu L; Yang H
    Brain Res; 2014 Dec; 1591():14-26. PubMed ID: 25446002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson's Disease.
    Battis K; Xiang W; Winkler J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Lipids in the Initiation of α-Synuclein Misfolding.
    Kiechle M; Grozdanov V; Danzer KM
    Front Cell Dev Biol; 2020; 8():562241. PubMed ID: 33042996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson's Disease.
    Chavarría C; Trostchansky A; Durán R; Rubbo H; Souza JM
    Adv Exp Med Biol; 2019; 1127():169-179. PubMed ID: 31140178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of α-synuclein with biomembranes in Parkinson's disease--role of cardiolipin.
    Ghio S; Kamp F; Cauchi R; Giese A; Vassallo N
    Prog Lipid Res; 2016 Jan; 61():73-82. PubMed ID: 26703192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.
    Xu MM; Ryan P; Rudrawar S; Quinn RJ; Zhang HY; Mellick GD
    Acta Pharmacol Sin; 2020 Apr; 41(4):483-498. PubMed ID: 31586134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-Synuclein and Lipids: The Elephant in the Room?
    Sarchione A; Marchand A; Taymans JM; Chartier-Harlin MC
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
    Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease.
    Alecu I; Bennett SAL
    Front Neurosci; 2019; 13():328. PubMed ID: 31031582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V63 and N65 of overexpressed α-synuclein are involved in mitochondrial dysfunction.
    Zhang H; Liu J; Wang X; Duan C; Wang X; Yang H
    Brain Res; 2016 Jul; 1642():308-318. PubMed ID: 27048753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease.
    Canerina-Amaro A; Pereda D; Diaz M; Rodriguez-Barreto D; Casañas-Sánchez V; Heffer M; Garcia-Esparcia P; Ferrer I; Puertas-Avendaño R; Marin R
    Front Neurosci; 2019; 13():382. PubMed ID: 31068782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein-112 Impairs Synaptic Vesicle Recycling Consistent With Its Enhanced Membrane Binding Properties.
    Soll LG; Eisen JN; Vargas KJ; Medeiros AT; Hammar KM; Morgan JR
    Front Cell Dev Biol; 2020; 8():405. PubMed ID: 32548120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.